MedTrace Logo

Treatment for Specific Phobias in Children

NCT00051220 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-06-07

No results posted yet for this study

Summary

This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.

Conditions

  • Phobic Disorders
  • Anxiety Disorders

Interventions

BEHAVIORAL

One-Session Treatment for Specific Phobias

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Virginia Polytechnic Institute and State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2006-09-30
Completion
2006-09-30

Countries

  • United States
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00051220 on ClinicalTrials.gov